Clinical trials
Coronary Disease trials in Germany with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 3 |
| 2014 | 3 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 2 |
| University of Göttingen | 2 |
| Universitätsklinikum Hamburg-Eppendorf | 2 |
| Biosensors Europe SA | 1 |
| Charite University, Berlin, Germany | 1 |
| Elixir Medical Corporation | 1 |
| Genossenschaft Gesundheitsprojekt Mannheim e.G | 1 |
| Heinrich-Heine University, Duesseldorf | 1 |
| Johann Wolfgang Goethe University Hospital | 1 |
| Johannes Gutenberg University Mainz | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Disease | 24 |
| Coronary Artery Disease | 7 |
| Coronary Stenosis | 4 |
| Myocardial Ischemia | 4 |
| Cardiovascular Diseases | 3 |
| Coronary Restenosis | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Heart Diseases | 3 |
| Breast Neoplasms | 2 |
| Diabetes Mellitus | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.